Comparison of bcr-abl protein expression and Philadelphia chromosome analyses in chronic myelogenous leukemia patients

American Journal of Clinical Pathology

Volumn 106, Issue 4, 1996, Pages 442-448

  Guo, Jie Qiang ^a   Lian, Jinying ^a   Glassman, Armand ^a   Talpaz, Moshe ^a   Kantarjian, Hagop ^a   Deisseroth, Albert B ^a   Arlinghaus, Ralph B ^a,b,c  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c Department of Cancer Research ^*  (United States)

Author keywords

bcr abl; Chronic myelogenous leukemia; Oncoprotein; Philadelphia chromosome leukemias; Western blotting

Indexed keywords

BCR ABL PROTEIN;

ARTICLE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CYTOGENETICS; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

EID: 10144250938     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/106.4.442     Document Type: Article

References (28)

1. Nowell PC, Hungerford DA. A minute chromosome in human chronic granulocytic leukemia. Science 1960;132:1497-1499.
2. Dreazen O, Klisak I, Jones G, et al. Multiple molecular abnormalities in Ph1 chromosome positive acute lymphoblastic leukaemia. Br J Haematol 1987;67:319-324.
3. Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973;243:290-293.
4. Shtivelman E, Lifshitz B, Gale RP, Canaani E. Fused transcripts of abl and bcr genes in chronic myelogenous leukemia. Nature 1985;315:550-553.
5. Shtivelman E, Lifshitz B, Gale RP, Roe BA. Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell 1986;47:277-284.
6. Haber LM, Childs CC, Hirsch-Ginsberg C, et al. Strategy for break-point cluster region analysis in chronic myelocytic leukemia in a routine clinical laboratory. Am J Clin Pathol 1990;95:762-767.
7. Kawasaki ES, Clark SS, Coyne MY, et al. Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci USA 1988;85:5698-5702.
8. Lee M-S, LeMaistre A, Kantarjian HM, et al. Detection of two alternative bcr-abl mRNAs and minimal residual disease in Philadelphia chromosome-positive chronic myelogenous leukemia by polymerase chain reaction. Blood 1989;73:2165-2170.
9. Roth MS, Antin JH, Bingham EL, Ginsburg D. Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia. Blood 1989;74:882-885.
10. Maurer J, Thiel E. Rapid detection of chimeric bcr/abl mRNAs in acute lymphoblastic and chronic myeloid leukemia by the polymerase chain reaction. Blut 1990;61:350-353.
11. Lee MS, Kantarjian HM, Talpaz M, et al. Detection of minimal residual disease by polymerase chain reaction in Philadelphia chromosome-positive chronic myelogenous leukemia following interferon therapy. Blood 1992;79:1920-1923.
12. Seong DC, Song MY, Henske EP, et al. Analysis of interphase cells for the Philadelphia translocation using painting probe made by inter-Alu-polymerase chain reaction from a radiation hybrid. Blood 1994;83:2268-2273.
13. Guo JQ, Wang JYJ, Arlinghaus RB. Detection of bcr-abl proteins in blood cells of benign phase chronic myelogenous leukemia patients. Cancer Res 1991;51:3048-3051.
14. Guo JQ, Hirsch-Ginsberg CF, Xian YM, et al. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia. Hematol Pathol 1993;7:91-106.
15. Guo JQ, Lian JY, Xian YM, et al. bcr-abl protein expression in peripheral blood cells of chronic myelogenous leukemia patients undergoing therapy. Blood 1994;83:3629-3637.
16. Konopka JB, Watanabe SM, Witte ON. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 1994;37:1035-1042.
17. Kloetzer W, Kurzrock R, Smith L, et al. The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activity. Virology 1985;140:230-238.
18. Mes-Masson AM, McLaughlin J, Daley GQ, et al. Overlapping cDNA clones define the complete coding region for the P210c-abl gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome. Proc Natl Acad Sci USA 1986;83:9768-9772.
19. Maxwell S, Kurzrock R, Talpaz M, Keating M, Gallick G, Kloetzer W, Arlinghaus R, Gutterman J. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients. Cancer Res 1987;47:1731-1739.
20. Kurzrock R, Shtalrid M, Romero P, et al. A novel c-abl protein in Philadelphia positive acute lymphoblastic leukemia. Nature 1987;325:631-635.
21. Chan LC, Karhi KK, Rayter SI, et al. A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia. Nature 1987;325:635-637.
22. Walker LC, Ganesan TS, Dhut S, et al. Novel chimaeric protein expressed in Philadelphia positive acute lymphoblastic leukaemia. Nature 1987;329:851-853.
23. Daley GQ, Van Etten RA, Baltimore D. Induction of chronic myelogenous leukemia in mice by the P210 bcr/abl gene of the Philadelphia chromosome. Science 1990;247:824-830.
24. Heisterkamp N, Jenster G, ten Hoeve J, et al. Acute leukemia in bcr/abl transgenic mice. Nature 1990;344:251-253.
25. Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 1975;45:321-334.
26. Koeffler HP, Golde DW. Acute myelogenous leukemia: A human cell line response to colony stimulating activity. Science 1978;200:1153-1155.
27. Bedi A, Zehnbauer BA, Collector MI, et al. bcr-abl gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia. Blood 1993;81:2989-2902.
28. Kantarjian HM, Smith TL, O'Brien S, et al. Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-A therapy. Ann Intern Med 1995;122:254-261.